Cargando…

Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India

BACKGROUND AND AIM: Patients with inflammatory bowel disease (IBD) are at a risk of nutritional deficits because of poor dietary beliefs and practices. There are no data on this aspect from Asia, which is experiencing a rise in IBD incidence. We aimed to establish dietary beliefs and practices in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomar, Sanjeevani K, Kedia, Saurabh, Upadhyay, Ashish D, Bopanna, Sawan, Yadav, Dawesh P, Goyal, Sandeep, Jain, Saransh, Makharia, Govind, Ahuja, Vineet, Singh, Namrata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207045/ https://www.ncbi.nlm.nih.gov/pubmed/30483527 http://dx.doi.org/10.1002/jgh3.12002

Ejemplares similares

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease
por: Tomar, Sanjeevani K, et al.
Publicado: (2019)

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Gupta, Akshita, et al.
Publicado: (2017)

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
por: Agarwal, Ashish, et al.
Publicado: (2018)

Left‐sided colitis and extensive colitis have similar colectomy rates after index episode of acute severe colitis: A long‐term follow‐up study
por: Jain, Saransh, et al.
Publicado: (2017)

Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration
por: Yadav, Dawesh P., et al.
Publicado: (2017)

Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study
por: Jain, Saransh, et al.
Publicado: (2018)

Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant role
por: Goyal, Sandeep, et al.
Publicado: (2017)

Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India
por: Harsh, Parnita, et al.
Publicado: (2017)

Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis
por: Kedia, Saurabh, et al.
Publicado: (2017)

Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer
por: Bopanna, Sawan, et al.
Publicado: (2016)

Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial
por: Kedia, Saurabh, et al.
Publicado: (2017)

Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
por: Sharma, Sanchit, et al.
Publicado: (2021)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
por: Kumar, Suraj, et al.
Publicado: (2017)

High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
por: Jain, Saransh, et al.
Publicado: (2021)

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
por: Kante, Bhaskar, et al.
Publicado: (2022)

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
por: Kumar, Peeyush, et al.
Publicado: (2023)

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
por: Vuyyuru, Sudheer K, et al.
Publicado: (2021)

High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
por: Kante, Bhaskar, et al.
Publicado: (2023)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Does the road to primary prevention of inflammatory bowel disease start from childhood?
por: Kedia, Saurabh, et al.
Publicado: (2022)

Tufting enteropathy: a rare anatomical cause of small bowel diarrhoea in infants with mild or no villous abnormality
por: Das, Prasenjit, et al.
Publicado: (2023)

Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019)

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study
por: Golla, Rithvik, et al.
Publicado: (2023)

Management of inflammatory bowel disease in older persons: evolving paradigms
por: Kedia, Saurabh, et al.
Publicado: (2018)

Opportunities and challenges in the management of celiac disease in Asia
por: Agarwal, Ashish, et al.
Publicado: (2020)

Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2022)

Development and Validation of a Smartphone Application for Telenutrition in Patients with Inflammatory Bowel Disease
por: Gupta, Arti, et al.
Publicado: (2022)

Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis
por: Ranjha, Raju, et al.
Publicado: (2015)

Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
por: Agarwal, Ashish, et al.
Publicado: (2021)

Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
por: Vuyyuru, Sudheer K., et al.
Publicado: (2021)

Prospective validation of CD4(+) CD25(+) FOXP3(+) T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
por: Rampal, Ritika, et al.
Publicado: (2021)

Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis
por: Markandey, Manasvini, et al.
Publicado: (2023)

Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
por: Kedia, Saurabh, et al.
Publicado: (2021)

Human gut microbiome: A primer for the clinician
por: Kedia, Saurabh, et al.
Publicado: (2023)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
por: Sachdeva, Karan, et al.
Publicado: (2023)

Is There True Gender Difference of Irritable Bowel Syndrome in Asia?: Author's Reply
por: Makharia, Govind K
Publicado: (2011)

An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease
por: Patel, Rajan N., et al.
Publicado: (2020)

CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease
por: Tiwari, Veena, et al.
Publicado: (2018)

Emergence of Celiac Disease and Gluten-related Disorders in Asia
por: Mohta, Srikant, et al.
Publicado: (2021)

The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical Dilemma
por: Makharia, Archita, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t4s04aa5497s8dspoi3g6s86kv